Merck Holds Groundbreaking Ceremony for Formulation Laboratory and Experimental Center

Merck (known as Merck, Sharp, and Dohme outside the United States and Canada) held the groundbreaking ceremony for its Formulation Laboratory, Experimental (FLEx) Center in Rahway, NJ, with its collaboration partners, including G-CON Manufacturing, the companies announced in a June 13, 2019 press release. In February 2019, Merck announced the selection of G-CON’s prefabricated, flexible cleanroom units (PODs) for the new FLEx Center based on the PODs’ flexibility, speed, and ability to be repurposed. The facility is designed to make manufacturing more agile and sustainable and will provide improved flexibility in pharmaceutical formulation and process development for both sterile and oral solid-dosage products. Construction has commenced, and the facility is scheduled to open in 2021. 

“The groundbreaking of the FLEx center at our Rahway, NJ site commences our journey to establish a world-class pharmaceutical processing facility that is reconfigurable with the evolving and dynamic technology needs of our pipeline,” said Allen C. Templeton, vice-president, Pharmaceutical Sciences at Merck Research Laboratories, in the press release. “We are pleased to collaborate with G-CON, along with other key construction and equipment providers, to enable our vision to create more effective means to develop and manufacture our products.”